
Headway in Alzheimer’s Disease Care: New Guidance Provides Recommendations for Use of Anti-Amyloid Monoclonal Antibodies
BASEL, SWITZERLAND, April 24, 2025 /EINPresswire.com/ -- The new guidelines for the use of monoclonal antibodies (mAbs) published in Neurodegenerative Diseases, serve as exemplary clinical recommendations for clinicians and healthcare providers, …